Recursion Pharmaceuticals reported cash from operations of -$105.95M and free cash flow of -$105.99M for the quarter ended Jun 2026, down 38.6% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -46.40M | -64.96M | -55.98M | -66.19M | -62.57M | -60.98M | -65.33M | -76.73M | -93.02M | -93.00M | -91.37M | -97.54M | -95.84M | -178.91M | -202.49M | -171.90M | -162.25M | -108.12M | -117.50M | -131.00M | ||||||
| Share-based CompensationStock Comp. | 3.36M | 4.34M | 7.55M | 3.76M | 8.91M | 7.70M | 8.81M | 89.98M | -7.77M | -1.76M | 16.13M | 16.52M | 18.25M | 579.22M | 36.06M | 26.16M | 25.24M | 23.76M | 22.21M | 19.50M | ||||||
| Deferred Taxes | -0.42M | 0.64M | -4.60M | -0.00M | ||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 2.81M | 1.17M | 0.02M | 0.11M | 5.96M | |||||||||||||||||||||
| Cash from OperationsCash from Ops. | -33.05M | -61.16M | 77.39M | -61.62M | -54.54M | -44.75M | -73.32M | -67.47M | -72.92M | -74.08M | -102.30M | -82.22M | -59.23M | -115.43M | -131.96M | -76.42M | -117.36M | -46.07M | -81.10M | -105.95M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 2.44M | 2.24M | 2.77M | 2.79M | 2.99M | 3.21M | 3.73M | 5.54M | 7.58M | 7.55M | 7.38M | 8.97M | 7.20M | 12.95M | 19.33M | 23.85M | 21.04M | 19.48M | 19.67M | 18.17M | ||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | -0.02M | |||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 3.13M | -3.51M | 1.34M | -0.99M | 0.71M | 0.69M | -0.34M | -2.52M | 2.19M | -0.32M | 1.17M | -1.34M | -1.51M | 8.12M | 3.69M | -4.84M | -5.89M | 4.42M | 2.07M | -7.67M | ||||||
| Change in Accured ExpensesChange Accured Exp. | 10.13M | 1.64M | -15.90M | 1.07M | 2.09M | 12.16M | -9.85M | 6.20M | 7.58M | 2.78M | -18.86M | 7.51M | 6.35M | 10.52M | -26.59M | 11.38M | -8.03M | 15.84M | -18.45M | 5.83M | ||||||
| Other Working Capital ChangesOther WC Changes | -2.50M | -2.50M | 144.70M | -7.65M | -13.05M | -13.68M | -12.13M | -11.07M | -10.16M | -7.72M | -13.65M | -12.64M | 3.92M | -5.66M | -9.76M | -13.62M | -6.63M | -6.76M | -2.25M | -7.30M | ||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital ExpendituresCapex | 9.71M | 4.46M | 4.34M | 16.48M | 8.26M | 7.98M | 5.17M | 3.97M | 0.74M | 2.07M | 6.65M | 1.18M | 4.56M | 1.30M | 1.83M | 3.15M | 0.24M | 1.24M | 0.26M | 0.04M | ||||||
| Acquisitions | 0.07M | -277.10M | ||||||||||||||||||||||||
| Divestments | -4.44M | |||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 69.19M | 147.65M | 21.41M | 61.55M | 0.48M | |||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -193.87M | -52.24M | 143.30M | 4.94M | 52.98M | -7.98M | -5.34M | -2.05M | -0.35M | -2.49M | -6.65M | -4.18M | -4.56M | 275.46M | -7.27M | -5.81M | -2.55M | -1.24M | -0.34M | -1.96M | ||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activitiesOther financing | -454.46M | 2.11M | 2.69M | 2.36M | 3.57M | 1.95M | 3.81M | 3.79M | 3.26M | 3.05M | 1.60M | 1.78M | 1.71M | 1.55M | 2.74M | -0.99M | 0.79M | |||||||||
| Cash from Financing ActivitiesCash from Financing | -11.10M | 3.80M | 2.08M | 2.67M | 2.34M | 147.26M | 1.92M | 3.79M | 53.77M | 80.66M | 13.90M | 263.12M | 16.46M | 10.64M | 40.53M | 97.66M | 251.34M | 132.01M | -3.47M | -1.27M | ||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 462.90M | 50.00M | 78.09M | 10.87M | 261.55M | 16.97M | 11.03M | 41.02M | 100.00M | 254.46M | 133.38M | |||||||||||||||
| Additional items | ||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.31M | -0.00M | 0.18M | -0.12M | 0.12M | -0.22M | -0.12M | 0.40M | -3.47M | 4.83M | 9.26M | 1.87M | 2.09M | -3.83M | 0.81M | |||||||||||
| Change in Cash | -238.02M | -109.61M | 222.78M | -54.02M | 0.78M | 94.22M | -76.73M | -65.55M | -19.62M | 4.22M | -95.28M | 176.60M | -46.92M | 167.19M | -93.87M | 24.69M | 133.30M | 86.78M | -88.74M | -108.36M | ||||||
| Free Cash FlowFCF | -42.75M | -65.62M | 73.05M | -78.10M | -62.80M | -52.73M | -78.49M | -71.44M | -73.67M | -76.14M | -108.95M | -83.40M | -63.79M | -116.73M | -133.79M | -79.57M | -117.60M | -47.32M | -81.36M | -105.99M | ||||||
| Net Cash FlowNCF | -238.02M | -109.61M | 222.78M | -54.02M | 0.78M | 94.53M | -76.73M | -65.73M | -19.50M | 4.09M | -95.06M | 176.72M | -47.33M | 170.66M | -98.70M | 15.43M | 131.43M | 84.69M | -84.91M | -109.17M |